What is the bismuth (Bismuth subsalicylate) treatment regimen for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bismuth Quadruple Therapy for H. pylori Infection

The recommended treatment for H. pylori infection is bismuth quadruple therapy for 14 days, which has an eradication rate of approximately 85% and is the preferred first-line treatment when antibiotic susceptibility is unknown. 1

Standard Bismuth Quadruple Therapy Regimen

The standard bismuth quadruple therapy consists of:

  • Proton pump inhibitor (PPI) - standard dose twice daily
  • Bismuth subsalicylate - 525 mg four times daily
  • Tetracycline - 500 mg four times daily
  • Metronidazole - 500 mg three to four times daily
  • Duration: 14 days

This regimen is particularly valuable because it avoids the issue of clarithromycin resistance, which is increasingly common worldwide 2.

Alternative Bismuth-Based Regimens

If the standard bismuth quadruple therapy is not available, the following alternatives can be considered:

  • Bismuth + PPI + Amoxicillin + Clarithromycin: This regimen has shown good safety outcomes 3, but should only be used in areas with low clarithromycin resistance.

  • Bismuth + PPI + Furazolidone + Tetracycline: This combination has demonstrated excellent eradication rates (SUCRA 97.5) in network meta-analyses 3.

Important Considerations

Antibiotic Resistance

  • Local antibiotic resistance patterns should guide therapy selection when available 1
  • Previously used antibiotics should be avoided in subsequent eradication attempts if first-line therapy fails 1, 4

Safety Considerations

  • Caution should be exercised when combining bismuth with PPIs, as acid suppression may increase bismuth absorption 5
  • Blood bismuth levels can reach the "alarm level" (50-100 μg/L) in approximately 8.8% of patients receiving bismuth with PPIs 5

Treatment Duration

  • 14-day treatment duration is strongly associated with better eradication rates compared to shorter regimens 6
  • The eradication rate increases to 93% (intention-to-treat) with 14-day bismuth quadruple therapy 6

Second-Line Options

If bismuth quadruple therapy fails:

  • Levofloxacin-based triple therapy for 10-14 days is recommended 1
  • Avoid antibiotics previously used in the failed regimen 1, 4

Special Populations

For patients with penicillin allergy:

  • Bismuth quadruple therapy with tetracycline is an excellent option as it does not contain amoxicillin 1

Confirmation of Eradication

  • Wait at least 4 weeks after completing antibiotic therapy before testing for H. pylori eradication 1
  • Use either urea breath test or stool antigen test (both have >90% sensitivity and specificity) 1

Bismuth quadruple therapy has emerged as the preferred first-line treatment for H. pylori infection due to increasing antibiotic resistance worldwide, particularly to clarithromycin. The 14-day regimen provides the highest eradication rates and should be the standard approach when antibiotic susceptibility testing is not available.

References

Guideline

Treatment of Patients with Helicobacter pylori Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2017

Research

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.